|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61K 9/14 | (2006.01) | ||
| A61K 31/635 | (2006.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2982366 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15184904.9 |
| Date of filing the European patent application | 2010-06-08 | |
| (97) | Date of publication of the European application | 2016-02-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-13 |
| (46) | Date of publication of the claims translation | 2017-11-27 |
| (30) | Number | Date | Country code |
| 185130 P | 2009-06-08 | US |
| (72) |
PACKHAEUSER, Claudia, DE
STEIGER, Norbert, DE
LIEPOLD, Bernd, DE
KOSTELAC, Drazen, DE
KNOBLOCH, Martin, DE
|
| (73) |
AbbVie Deutschland GmbH & Co. KG,
Mainzer Strasse 81, 65189 Wiesbaden,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė vaisto forma, skirta BCL-2 šeimos inhibitorių peroraliniam vartojimui |
| PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL-2 FAMILY INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-05-09 | 15 | 289.00 EUR |
| 2025-06-08 |